Related references
Note: Only part of the references are listed.Adverse Effects of Low-Dose Methotrexate A Randomized Trial
Daniel H. Solomon et al.
ANNALS OF INTERNAL MEDICINE (2020)
Methotrexate and its mechanisms of action in inflammatory arthritis
Bruce N. Cronstein et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Concomitant use of low-dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis
Henrik Svanstrom et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2018)
Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study
Jeffrey A. Sparks et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
High Methotrexate Triglutamate Level Is an Independent Predictor of Adverse Effects in Asian Indian Rheumatoid Arthritis Patients-A Preliminary Study
Amit Sandhu et al.
THERAPEUTIC DRUG MONITORING (2017)
Relative risk of and determinants for adverse events of methotrexate prescribed at a low dose: a systematic review and meta-analysis of randomized placebo-controlled trials
C. Mazaud et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Methotrexate Polyglutamate Monitoring in Patients With Crohn's Disease
Monika Fischer et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes The TRACER Trial
Pascal Vranckx et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in juvenile idiopathic arthritis patients
Maja Bulatovic Calasan et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis
Maurits C. F. J. de Rotte et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Measuring methotrexate polyglutamates in red blood cells: a new LC-MS/MS-based method
E. den Boer et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2013)
The Effect of Genotype on Methotrexate Polyglutamate Variability in Juvenile Idiopathic Arthritis and Association With Drug Response
Mara L. Becker et al.
ARTHRITIS AND RHEUMATISM (2011)
Determinants of Red Blood Cell Methotrexate Polyglutamate Concentrations in Rheumatoid Arthritis Patients Receiving Long-Term Methotrexate Treatment
Lisa K. Stamp et al.
ARTHRITIS AND RHEUMATISM (2009)
Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study
T Dervieux et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis
P Dolezalova et al.
RHEUMATOLOGY (2005)
Share Paper
